ARCHIVES

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Federal Budget Cuts Implemented March 1; HHS Agencies Grapple with Consequences

March 8, 2013

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Funding Opportunities.

July 19, 2002